After Hours Summary
 ORCL +3.6%, RIMM +2.2% Following Earnings/Guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings: SMOD +9.9%, TTWO +6.0%, ORCL +3.6%, ZQK +3.6%, RIMM +2.2%, CAN +2.1%.

Companies trading higher in after hours in reaction to news: MA +2.2% (NRF Says Federal Reserve Action on Debit Cards Could Lead to Discounts for Consumers).

Nymox Pharma and Recordati announce European licensing agreement for NX-1207  (4.46 +0.04)
Recordati (Milan:REC) and NYMX announced the signing of a European licensing agreement for the development and commercialization of NX-1207, Nymox's Phase III investigational drug currently in clinical development in the U.S. for the treatment of benign prostatic hyperplasia (BPH). Under the terms of the agreement, Recordati receives exclusive rights to develop and subsequently market and sell NX-1207 in Europe including Russia and the CIS, the Middle East, the Maghreb area of North Africa and South Africa (i.e. a total of 81 countries). The licensing agreement covers the use of NX-1207 for the treatment of BPH as the initial indication for development and commercialization. Recordati will make an upfront payment to Nymox of EUR 10 mln (~$13 mln); approval and sales milestones payments; and tiered supply and royalty payments of a minimum of 26% to increase progressively up to 40% of total net sales in the case specific contractual conditions are achieved

Earnings

Before: CCL

After:

Events

ABC 2010 Investor Day

GPRO Annual Analyst Day